The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 05, 2011
Filed:
Feb. 25, 2005
Applicants:
Takehiko Sasahara, Numazu, JP;
Mitsunobu Mohri, Mishima, JP;
Ken-ichi Kasahara, Shizuoka, JP;
Inventors:
Assignee:
Asahi Kasei Pharma Corporation, Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 1/16 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 9/10 (2006.01); A61K 31/22 (2006.01); A61K 31/366 (2006.01); A61K 31/38 (2006.01); A61K 31/381 (2006.01); A61K 31/395 (2006.01); A61K 31/4025 (2006.01); A61K 31/428 (2006.01); A61K 31/439 (2006.01); A61K 31/4995 (2006.01); A61K 31/5375 (2006.01); A61K 31/541 (2006.01); A61K 31/554 (2006.01); C07D 281/10 (2006.01); C07D 337/08 (2006.01); C07D 409/12 (2006.01); C07D 453/02 (2006.01); C07D 471/08 (2006.01); C07D 487/08 (2006.01);
U.S. Cl.
CPC ...
Abstract
A pharmaceutical useful as a therapeutic agent and a preventive agent for hyperlipemia, and a pharmaceutical useful as a therapeutic agent and a preventive agent for hepatic disorders associated with cholestasis, particularly, primary biliary cirrhosis and primary sclerosing cholangitis, and a pharmaceutical useful as a therapeutic agent and a preventive agent for obesity, fatty liver and steatohepatitis are provided. A benzothiazepine or benzothiepine compound represented by the following formula (1A) having a thioamide bond and a quaternary ammonium substitutent: